William Blair & Company’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-6,246
Closed -$223K 1793
2023
Q4
$223K Buy
6,246
+10
+0.2% +$372 ﹤0.01% 1360
2023
Q3
$273K Sell
6,236
-250
-4% -$12.2K ﹤0.01% 1276
2023
Q2
$320K Sell
6,486
-317
-5% -$14.6K ﹤0.01% 1223
2023
Q1
$282K Sell
6,803
-483
-7% -$20K ﹤0.01% 1266
2022
Q4
$323K Buy
+7,286
New +$304K ﹤0.01% 1198
2018
Q1
Sell
-10,440
Closed -$190K 1514
2017
Q4
$190K Sell
10,440
-32,200
-76% -$638K ﹤0.01% 1274
2017
Q3
$954K Hold
42,640
0.01% 741
2017
Q2
$1.03M Hold
42,640
0.01% 742
2017
Q1
$817K Sell
42,640
-56,395
-57% -$988K 0.01% 764
2016
Q4
$1.94M Sell
99,035
-11,735
-11% -$213K 0.02% 498
2016
Q3
$1.75M Buy
110,770
+10,585
+11% +$163K 0.02% 522
2016
Q2
$1.42M Buy
100,185
+44,520
+80% +$679K 0.01% 538
2016
Q1
$937K Buy
55,665
+940
+2% +$16.5K 0.01% 630
2015
Q4
$1.23M Buy
+54,725
New +$1.13M 0.01% 580

Other funds holding ATRC

William Blair & Company's ATRC Position: Q1 2024 in Review

William Blair & Company sold out of AtriCure (ATRC) in Q1 2024, closing a stake of 6,246 shares — an estimated $223K sold.

William Blair & Company first reported a position in ATRC in Q4 2015 and held it in 14 quarters. The position peaked at $1.94M in Q4 2016. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2024.

  • William Blair & Company reported no remaining AtriCure position as of Q1 2024 after selling out during the quarter.
  • William Blair & Company sold 6,246 AtriCure shares in Q1 2024, an estimated $223K.
  • William Blair & Company first reported a position in AtriCure in Q4 2015 and held it in 14 quarters.
  • William Blair & Company's AtriCure position peaked at $1.94M in Q4 2016.
  • 224 funds tracked by Wall St. Rank held AtriCure as of Q1 2024.

Based on William Blair & Company's 13F filing for Q1 2024, filed 9 May 2024.